---
title: "Gabapentin - Restless Legs Syndrome"
sidebar: mydoc_sidebar
permalink: db00996-mesh-d012148-1.html
toc: false 
---


Path ID: `DB00996_MESH_D012148_1`
{% include image.html url="images/db00996-mesh-d012148-1.png" file="db00996-mesh-d012148-1.png" alt="db00996-mesh-d012148-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000077206 | gabapentin | Drug |
| UniProt:P54289 | voltage dependent calcium channel alpha-2-delta | Protein |
| GO:0006936 | Muscle Contraction | BiologicalProcess |
| MESH:D012148 | Restless Legs Syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Gabapentin | DECREASES ACTIVITY OF | Voltage Dependent Calcium Channel Alpha-2-Delta |
| Voltage Dependent Calcium Channel Alpha-2-Delta | PARTICIPATES IN | Muscle Contraction |
| Muscle Contraction | NEGATIVELY CORRELATED WITH | Restless Legs Syndrome |
|---------|-----------|---------|

Reference:
  - [https://go.drugbank.com/drugs/DB00996#mechanism-of-action](https://go.drugbank.com/drugs/DB00996#mechanism-of-action){:target="_blank"}